AI is accelerating in terms of speed and capabilities, enabling it to do things only humans COULD DO, meaning convergence (SINGULARITY) is coming.

STEM has spent nearly two decades supporting pharma companies with strategic insights. As Adam Boucher explained, the emergence of generative AI has opened new possibilities for analysing field ...